Strattera Side Effects

The documented risks of these drugs are provided so the public can make informed, educated decisions. Strattera is a newer antidepressant drug though it is marketed for “ADHD”. The U.S. Food and Drug Administration warns that antidepressants can cause suicidal thinking and behavior in children and young adults. Strattera is also known as Atomoxetine.

To see the total figures from IQVia on the number of people taking antidepressants in the U.S., click here.

Please note: No one should attempt to get off of psychiatric drugs without a doctor’s supervision. To help find medical practitioners in your area, click here.

Also, read the FDA’s Strattera Medication Guide for more information. MedGuides include “the particular serious and significant public health concern that has created the need for the Medication Guide” and notes “pediatric risks.” (Note: Unfortunately, the FDA MedGuides only work on a desktop, not on a mobile device. Please complain to the FDA to make their public advisories accessible to all. 1-888-INFO-FDA or 1-888-463-6332.)




Strattera Drug Warnings:

There have been 27 drug regulatory agency warnings from eight countries (Australia, Canada, Denmark, Ireland, New Zealand, Russia, United Kingdom and United States) and the European Union on Strattera (or atomoxetine). These include the following (note that some warnings cite more than one side effect, so the list below may not be equal to the total number of warnings):

11 warnings on Strattera causing heart problems
9 warnings on Strattera causing suicide risk or suicidal behavior
8 warnings on Strattera causing blood pressure changes or high or low blood pressure
7 warnings on Strattera causing cardiovascular disorders
4 warnings on Strattera causing hostility or aggression
4 warnings on Strattera causing agitation
4 warnings on Strattera causing mania or psychosis
4 warnings on Strattera causing liver problems
4 warnings on Strattera causing hallucinations
2 warnings on Strattera causing involuntary movements
2 warnings on Strattera causing seizures or convulsions
1 warning on Strattera causing anxiety
1 warning on Strattera causing abnormal behavior
1 warning on Strattera causing muscle problems
1 warning on Strattera causing self-harm
1 warning on Strattera causing sleep problems
1 warning on Strattera causing irritability
1 warning on Strattera causing death or increased risk of death
1 warning on Strattera causing depression
1 warning on Strattera causing stroke

Strattera Drug Studies:

There have been eight studies done in 12 countries (Australia, Belgium, China, Denmark, Germany, Hungary, Ireland, italy, Netherlands, Scotland, United Kingdom and United States) on Strattera (or atomoxetine). These include the following (note that some studies cite more than one side effect, so the list below may not be equal to the total number of studies):

2 studies on Strattera causing mania or psychosis
1 study on Strattera causing cardiovascular disorders
1 study on Strattera causing newborn complications
1 study on Strattera causing pregnancy complications
1 study on Strattera causing violence
1 study on Strattera causing heart problems
1 study on Strattera causing hostility or aggression
1 study on Strattera causing lowered bone mass
1 study on Strattera causing blood pressure changes or high or low blood pressure
1 study on Strattera causing hallucinations
1 study on Strattera causing irritability
1 study on Strattera having lack of efficacy

This brochure is a simple guide that documents the dangerous and deadly side effects of the drugs prescribed to millions of men, women and children diagnosed with bogus mental disorders.